CACLP Is Undergoing, the Special Satellite Conference of Uni-medica Has Been Successfully Hosted

2023-05-29

CACLP is undergoing! Uni-medica is exhibiting the products like Total Solution of Intelligent Fluorescent Morphology of Gynecological Inflammation, Targeted Sequencing Kit for Pathogen Detection (tNGS), and Full Product Line of Flow Cytometry Detection and so on.

On the first day of the exhibition, Uni-medica has successfully hosted the special satellite conference. Moreover, it was of high popularity at the Uni-medica's booth.

The Special Satellite Conference

Uni-medica's press conference,"Innovative Solutions for Pathogenic Infection and Gynecological Inflammation", was held on time in Conference Room 101 from 13:00 to 15:00 on May 28th, and meanwhile it was broadcast live on its WeChat Channel. The satellite meeting was popular, while the specialists and guests were in high spirits.

The meeting was hosted by Qiu Guangbin, the former director of the laboratory department of 202 Hospital.

Min Qinghua, the director of the Department of Obstetrics and Gynecology of the First Affiliated Hospital of Nanchang University, shared the theme of "Application of Automatic Fluorescence Staining Detection Technology in Gynecological Vaginitis" with the guests.

Li Yunhui, the director of the Laboratory Department of General Hospital of the Northern Theater Command, shared with the guests about "Application of tNGS, a new technology for ultra-multiplex PCR targeted sequencing, in respiratory tract infections".

In the end, Guo Yongchao, the chairman of Uni-medica, made a concluding speech.

High Popularity of the Booth

About Uni-medica

Shenzhen Uni-medica Technology Co., Ltd (Uni-medica) is a national high-tech enterprise. It has established cooperation and jointly performed a number of scientific research projects with the Hong Kong University of Science and Technology, Shenzhen University and Chinese Academy of Sciences. Uni-medica was also selected as one of the top 100 new Chinese innovative enterprises. 

The company takes the technical innovation of molecular detection methods as the core driving force, and focuses on the R&D and industrialization  of molecular diagnostic products aiming at prevention and control of infectious diseases and genetic diseases.

Uni-medica provides total solution of accurate diagnosis of infectious diseases and genetic diseases based on multi-omics technologies, including multiplex PCR, NGS technology and flow cytometry.

Uni-medica is qualified by ISO 13485 and NMPA quality control system. The pathogen molecular detection products are daily used in hundreds of hospitals, Centers for Disease Control and Prevention and Quarantine Laboratories throughout the country, providing strong support for prevention and control of infectious diseases.